Abstract. Fluorescence molecular tomography ͑FMT͒ has emerged as a means of quantitatively imaging fluorescent molecular probes in three dimensions in living systems. To assess the accuracy of FMT in vivo, translucent plastic tubes containing a turbid solution with a known concentration of Cy 5.5 fluorescent dye are constructed and implanted subcutaneously in nude mice, simulating the presence of a tumor accumulating a fluorescent molecular reporter. Comparisons between measurements of fluorescent tubes made before and after implantation demonstrate that the accuracy of FMT reported for homogeneous phantoms extends to the in vivo situation. The sensitivity of FMT to background fluorescence is tested by imaging fluorescent tubes in mice injected with Cy 5.5-labeled Annexin V. For small tube fluorochrome concentrations, the presence of background fluorescence results in increases in the reconstructed concentration. This phenomenon is counteracted by applying a simple subtraction correction to the measured fluorescence data. The effects of varying tumor photon absorption are simulated by imaging fluorescent tubes with varying ink concentrations, and are found to be minor. These findings demonstrate the in vivo quantitative accuracy of fluorescence tomography, and encourage further development of this imaging modality as well as application of FMT in molecular imaging studies using fluorescent reporters.
Introduction
In vivo observation and imaging of living subjects using fluorescence is one of the most rapidly evolving fields in clinical and experimental biology. Fluorescent probes offer a number of practical advantages in that they are inexpensive, present straightforward synthetic and conjugation chemistries, and emit detectable, nonionizing photons on excitation. A variety of strategies have been developed to image specific cellular and biochemical events in vivo using targeted and/or activatable fluorochromes conjugated to biocompatible delivery vehicles suitable for systemic injection. Imaging of cell-surface receptors and antigens has been accomplished in animal models using fluorescently labeled antibodies and antibody fragments, 1, 2 proteins that bind cell-surface moieties, 3 and peptides that bind to cell-surface receptors. 4, 5 Self-quenched fluorescent probes activated by specific proteolytic cleavage 6 or specific nucleic acid binding 7 have also been developed for in vivo use, allowing functional biochemical imaging of living subjects. Imaging of gene expression via fluorescence has been achieved using genetically encoded fluorescent reporters such as green fluorescent protein ͑GFP͒. 8 With advances in fluorescent probe technology, corresponding improvements in fluorescence imaging have also been achieved. Fluorescence has historically been used as a means of contrast in microscopy, [9] [10] [11] [12] a technique that has also been applied to living subjects through the use of intravital windows. 13, 14 Photographic techniques such as fluorescence reflectance imaging ͑FRI͒ have been applied toward imaging macroscopic fluorescent signatures deeper in tissues. 5, 8, [15] [16] [17] [18] Such methods have offered a simple means of imaging the distribution and/or activation of fluorescent probes in living subjects, and can provide semiquantitative results when the sizes and tissue depths of the imaging targets are properly controlled. However, as FRI is a single projection technique, it is unable to provide fully quantitative results because of nonlinear depth-dependent photon absorption in the subject. [19] [20] [21] To quantitatively image fluorescence in this situation, tomographic methods have been adopted. Hardware and software for in vivo fluorescence imaging have been developed, including means for localizing fluorophores in diffuse media 22, 23 as well as tomographically resolving fluorophore distributions, [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] as demonstrated with simulated and phantom data. Recently, these techniques have been applied to the observation of protease activity 38 and of chemotherapeutic action 21 in mouse models. These efforts have resulted in the emergence of fluorescence-mediated tomography ͑FMT͒ as a technique for quantitative in vivo molecular imaging using fluorescent agents.
Phantom experiments using known fluorochrome concentrations have demonstrated the accuracy of FMT employing a normalized Born reconstruction strategy in measuring fluorochrome concentrations in homogeneous media. 34, 38 However, it has not been established that the quantitative performance of fluorescence tomography observed in vitro extends to the in vivo situation. This validation includes not only evaluation of the quantitative accuracy of FMT for fluorescent objects in living subjects, but also determining how factors such as background fluorescence and local optical properties affect this accuracy. These questions are directly applicable to biological situations involving quantitation of a fluorescent target, such as a tumor that has been labeled through accumulation and/or activation of a fluorescent probe. In such an experiment, one wishes to absolutely determine the fluorochrome concentration and hence probe accumulation/ activation within the tumor. This measurement should ideally be independent of low levels of background fluorescence in surrounding tissue as well as the optical properties of the tumor itself, which are in part determined by its blood content and vascularity.
The extent to which FMT satisfies these criteria was investigated in this study by imaging tumor-like phantoms containing known concentrations of fluorescent dye before and after subcutaneous implantation in nude mice. Comparisons were made between reconstructions of FMT data acquired before and after implantation of the fluorescent tubes, allowing estimation of the sensitivity of FMT to the optical heterogeneity of the surrounding mouse tissues. In addition, identical tubes were imaged in mice after intravenous injection of a fluorescent probe targeting phosphatidylserine, a cell surface moiety implicated in cellular apoptosis. The selection of this probe represents a realistic case of a nonactivatable probe that typically yields background fluorescence signals due to nonspecific biodistribution. This case allowed observation of the effects of background, nonspecific fluorescence on the quantitation of a fluorescent focus. Finally, the influence of local optical heterogeneities on quantitation accuracy were assessed by imaging implanted fluorescent tubes with varying ink concentrations. From these experiments, it was observed that large dataset fluorescence tomography using a normalized Born reconstruction methodology can offer reliable quantification performance in vivo.
Methods and Materials

Fluorescent Tube Construction and Implantation
A turbid fluorescent medium simulating fluorochromes embedded in tissue was created by adding Cy 5.5 fluorescent dye ͑peak excitation 670 nm, peak emission 710 nm͒ to a solution of 1% intralipid and black india ink. The exact concentrations of Cy 5.5 and ink varied based on the experiment and are described in detail later. Translucent plastic tubes of inner diameter 1.5, wall thickness 0.25 mm, and length 8 mm, as shown in Fig. 1 , were sealed at one end and filled with 6 L of the fluorescent medium. The end of the tube was then sealed by melting the plastic at the opening. All animals were treated in accordance with the regulations of Massachusetts General Hospital. Nude mice ͑nu/nu, COX-7͒ were prepared for fluorescent tube placement by administration of general anesthesia through an intraperitoneal injection of ketamine ͑80 mg/ kg͒ and xylazine ͑12 mg/ kg͒. A 5-mm incision was made in the skin at the superior aspect of the ventral mammary fat pad, and a subcutaneous pocket approximately 10 mm long was made by separating the skin from the underlying muscle. A fluorescent tube was completely inserted into the subcutaneous pocket, after which the mouse was imaged with the system and protocol discussed in the next section. The tube was then removed and the implantation and imaging procedure was repeated using a new tube, depending on the experiment as detailed next. A single dose of anesthesia for a mouse was sufficient for fluorescent tube implantation and the acquisition of all subsequent data. After completion of the imaging battery and while still under anesthesia, the mice were euthanized by an overdose of halothane.
Data Acquisition and Analysis
A CCD-based parallel-plate imaging chamber designed for fluorescence reflectance and tomographic imaging of mice was used for all imaging experiments in this study. 34 A diagram of the imaging chamber setup is shown in Fig. 1 . After positioning each subject within the chamber and adjusting the plates to a separation of 13 mm, an imaging examination consisting of four image sets was acquired. Initially, an image of the subject was obtained under white light illumination to determine the position of the target and extract the location of each of the tomographic sources. A diode laser of wavelength 670 nm was then used to illuminate the subject in a reflectance geometry, and an FRI image was acquired by placing a four-cavity bandpass filter centered at 710 nm and a longpass filter with a cutoff wavelength of 695 nm in front of the CCD camera. The subject was then immersed in a 1% intralipid and 50 ppm black india ink solution ͑ a = 0.3 cm −1 , s Ј = 8.0 cm −1 ͒, designed to match the bulk optical properties of mice, 39 for acquisition of the tomographic data. Images of the photon distribution at the fluorescent excitation wavelength at the detector window were acquired for each of the 32 tomographic sources, spanning a field of view of 18ϫ 12 mm, using a four-cavity bandpass filter centered at 670 nm and a 1.5 optical density neutral density filter. The corresponding images at the fluorescent emission wavelength were then obtained using the same filter set as was employed for FRI. These images comprise a set of transillumination measurements at the fluorescent excitation and emission wavelengths, and constitute the raw dataset used for subsequent tomographic reconstruction.
After resampling the excitation and emission images to detector grids of 19ϫ 13 over a 18ϫ 12-mm field of view and correcting for the effects of the filter sets used, these data were reconstructed using a computationally efficient normalized Born approach employing a homogeneous slab solution to the diffusion equation. 28 Briefly, the normalized Born field was calculated by dividing the emission images, corrected for filter bleedthrough of excitation light, by the excitation images. Fluorescence measurements less than ten standard deviations above the noise level of the emission acquisitions were ignored. This measurement, deemed U nB , can be related to the spatial fluorochrome concentration distribution n͑r͒ by the expression
where U͑r s , r͒ is the photon field at the excitation wavelength 1 induced at position r by a source at position r s , and G͑r d − r͒ is the Green's function describing photon propagation at the emission wavelength 2 from a point r to a detector at location r d . For this experimental setup, a Green's function describing photon propagation through a slab was used to model light passing through the rectangular chamber enclosing the subject, filled with an intralipid-ink matching fluid. D is the diffuse medium diffusion coefficient, is the speed of light in the medium, and S 0 is an experimentally determined calibration factor that collectively accounts for the laser power and the unknown gain and attenuation factors of the system. This expression was discretized and inverted to solve for n͑r͒ using 20 iterations of an arithmetic reconstruction technique inversion procedure using randomly ordered projections. 40 The initial voxel estimates for n͑r͒ were set to zero.
The result of the reconstruction was a 3-D grid with 28 ϫ 20ϫ 18 elements over a 20ϫ 14ϫ 12-mm field of view representing the fluorochrome concentration in the chamber. This field of view was chosen as it allowed the acquisition of a high resolution dataset over a volume that included both the target as well as surrounding anatomy. Reconstructions were performed on a Pentium 4 PC with a processor clock speed of 2.4 GHz and 1 gigabyte of RAM ͑Dell, Austin, Texas͒. The mean intensity of the reconstructed fluorescent tube was calculated by averaging the intensity of voxels in a five by five neighborhood from the slice in the reconstructed volume corresponding to the location of the tube. The neighborhood was centered on the voxel with the maximum voxel intensity in the slice. The correspondence between the location of these voxels and the location of the fluorescent tube was verified visually through comparison with the white light and fluorescent reflectance images. Artifacts encountered in voxels near the sources and detectors, because of the large weights associated with them in the forward model, were avoided by excluding slices at the edges of the reconstructed volume from the analysis. For these experiments, this was not a significant concern, as the target was positioned outside these locations.
Influence of Biological Optical Heterogeneity
Fluorescent tubes with Cy 5.5 concentrations of 0, 250, 500, and 1000 nM ͑0, 1.5, 3, and 6 picomoles Cy 5.5 in 6 L of solution͒ and an ink concentration of 50 ppm were constructed. The tubes were first sequentially implanted in a nude Fig. 1 The experimental setup used for the in vivo measurements. A small plastic tube filled with a turbid intralipid/ink/Cy 5.5 solution is implanted in a nude mouse, which is then placed in an imaging chamber and bathed in an intralipid and ink optical matching fluid. A 670-nm wavelength laser diode, suitable for the excitation of Cy 5.5 fluorescent dye, is routed into a two-channel optical switch. Light is then routed either into a lamp adjacent to the detection apparatus, facilitating FRI, or into a multichannel optical switch that controls the excitation sources used for FMT. Photon detection is accomplished with a CCD camera focused on a window implanted in the imaging chamber. Appropriate bandpass filters are used to selectively detect fluorescent excitation or emission photons.
mouse and imaged with the FRI/FMT system, generating data hereafter referred to as the in vivo measurements. The fluorescent tubes were then removed from the mouse and sequentially imaged again while suspended in the 1% intralipid, 50-ppm ink optical matching fluid, positioned just behind the glass window as they were while in the subcutaneous space. These data are hereafter referred to as the ex vivo measurements. Reconstructions of the in vivo and ex vivo measurements were compared to assess the effect of the heterogeneous optical medium of the mouse of the ability of FMT to resolve fluorochrome concentrations. This experiment was repeated three times to obtain an estimate of the variability of the findings.
Influence of Background Fluorescence
To observe the effects of low levels of distributed background fluorescence on the quantitation of a fluorescent target, a nude mouse was injected with 1.0 nM of Cy 5.5-labeled Annexin V, a fluorescent probe with affinity for apoptotic cells exhibiting phosphotidylserine on the outer leaflet of the cell membrane. 3 Because this probe is nonactivatable ͑i.e., constitutively fluorescent͒, it produces detectable levels of fluorescence in nonapoptotic tissues because of nonspecific distribution by the vascular system. Given typical mouse body masses and volumes and the biodistribution of Annexin V, we estimate that this will result in a background Cy 5.5 concentration of approximately 50 nM. After allowing the probe to circulate for 1.5 h, tubes with Cy 5.5 concentrations of 0, 250, 500, and 1000 nM ͑0, 1.5, 3, and 6 picomoles Cy 5.5 in 6 L of solution͒ and an ink concentration of 50 ppm were consecutively implanted subcutaneously and imaged with FRI and FMT. This model therefore simulates a fluorescent tumor in the presence of a background of distributed, nonspecific fluorescence. The tubes were then removed from the Cy 5.5 Annexin V injected mouse and imaged again after implantation into a nude mouse that had not been injected with the probe.
FMT datasets were reconstructed using a single calibration factor S 0 determined from the in vivo fluorescent tube experiments in the previous section. Comparisons between measurements made with and without a circulating probe demonstrated the effects of background signals on FMT reconstructions. As previously stated, the experiment was repeated three times. We further investigated whether a simple offset subtraction could correct for the influence of background fluorochromes on the quantitation of a fluorescent focus. To accomplish this, the data acquired from mice injected with Cy 5.5 Annexin V were reconstructed a second time after subtracting a value of 20 counts/ s from every measurement of the fluorescence field. The offset of 20 counts/ s was determined by calculating the counts over a region of interest distant from the fluorescent tube in the fluorescent measurements taken from multiple mice injected with the Annexin V Cy 5.5 probe.
Influence of Target Absorption
Fluorescent tubes with ink concentrations of 25, 50, and 100 ppm and a Cy 5.5 concentration of 500 nM ͑3 picomoles Cy 5.5 in 6 L of solution͒ were constructed to simulate tumors with the same level of fluorescence but different absorption coefficients, corresponding to the biological situation of tumors with different degrees of vascularity and hence blood-related photon absorption. These tubes were sequentially implanted subcutaneously and imaged with FRI and FMT. Reconstructions of the FMT, calibrated using a factor determined from the in vivo measurements in the first section, were inspected to determine the effects of local optical properties within the imaging target on the fluorochrome concentrations measured by FMT. As before, the experiment was repeated three times.
Results
A total of 39 FRI/FMT datasets were acquired from six nude mice over the course of the experiments described. A single FRI/FMT examination, including insertion of the fluorescent tube, positioning of the mouse within the imaging chamber, and acquisition of a single FRI and FMT dataset, required approximately 10 min. Reconstruction of raw FMT data into a 3-D fluorochrome distribution was completed in approximately 5 min per dataset. Figure 2͑a͒ shows a representative reconstructed FMT dataset as a series of coronal slices, parallel to the source and detector planes. Reconstructed FMT slices acquired from a fluorescent tube containing 1000 nM Cy 5.5, imaged first by itself and then again after subcutaneous implantation in the mammary fat pad of a nude mouse, are shown overlaid on corresponding white light images in Figs. 2͑b͒ and 2͑c͒. In these overlays, FMT pixels with values less than the minimum of the colorbar were made transparent so as to visualize the location of the FMT focus relative to the white light image. The FMT slices represented are 0.6 mm-thick sections located 1.6 mm behind the glass observation window of the chamber, which is the expected position of the tube given its placement. In both measurements, the tube reconstructs as a fluorescent cylinder with dimensions of approximately 3 by 1.5 mm, as determined by full width at half maximum, which correlates with the volume and dimensions of the fluorochrome solution within the plastic tube ͑6 L, 3.3 mm long, with a 1.5 mm diameter͒. The quantitated fluorochrome concentrations from each situation are within 10% of each other, with the values in the in vivo case being slightly elevated relative to the ex vivo case.
Influence of Biological Optical Heterogeneity
The average fluorochrome concentrations for tubes with Cy 5.5 concentrations of 0, 250, 500, and 1000 nM imaged in vivo and ex vivo are plotted in Fig. 2͑d͒ . For each concentration, the FMT measurement acquired with the fluorescent tube implanted subcutaneously ͑triangles͒ reconstructed to fluorochrome concentrations 10 to 20% larger than the corresponding measurement acquired with the tube immersed in intralipid ͑circles͒. Both the in vivo and ex vivo measured fluorochrome concentrations are within 5 to 10% of the actual fluorochrome concentration, as identified by the dotted line. These data were used to calculate a single calibration factor S 0 to account for the unknown laser strength and CCD gain, and convert reconstructed values to absolute fluorochrome concentrations. This calibration factor is used in all subsequent measurements.
Influence of Background Fluorescence
A slice from the FMT reconstruction of a 500 nM fluorescent tube implanted in mice preinjected with Cy 5.5-labeled Annexin V are shown in Fig. 3͑b͒ , while a corresponding FMT slice acquired from a mouse that was not injected with a probe is shown in Fig. 3͑a͒ . The slices were taken from the same locations as those presented in Figs. 2͑b͒ and 2͑c͒ . The reconstructed volumes in these images have dimensions of 2.5 by 2 mm, and are more spherical than those obtained with the 1000 nM phantom in Fig. 2 . It is immediately apparent that in addition to the fluorescent tube, background heterogeneities are present in the reconstructions of data for which the mouse was initially injected with a fluorescent agent. The effects of these heterogeneities on quantitation of the fluorescent tubes are shown graphically in Fig. 3͑d͒ , in which average fluorochrome concentrations measured by FMT are plotted as a function of the tube Cy 5.5 concentration. The trace representing acquisitions made in a mouse with no circulating probe ͑circles͒ closely follows the actual fluorochrome concentrations, shown as a dotted line. The reconstructions of data acquired from a mouse injected with Cy 5.5-labeled Annexin V ͑squares͒, however, demonstrate a pronounced deviation from the actual values at lower tube fluorochrome concentrations ͑0 to 500 nM͒. For the 1000 nM fluorescent tube experiment, the traces for the two acquisitions converge.
A simple correction for background fluorescence was applied by subtracting 20 counts/ s from all fluorescence measurements prior to solving the inverse problem. Fluorochrome concentrations reconstructed from these corrected FMT datasets are shown in the red trace in Fig. 3͑d͒ . The result of the correction is that reconstructed FMT fluorochrome concentrations approach those obtained from the same fluorescent tubes imaged in mice without background fluorescence. The effect of this correction on the reconstructed image is shown in Fig. 3͑c͒ , which shows the FMT slice from Fig. 3͑b͒ reconstructed after dc subtraction. The background heterogeneities in the image are reduced, and the reconstructed fluorochrome concentrations in the focus approach the values measured from the fluorescent tube in a mouse with no background fluorescence.
Influence of Target Absorption
The effect of varying local absorption on FMT measurements was assessed by imaging fluorescent tubes containing 500 nM Cy 5.5 and 25, 50, or 100 ppm black india ink, as shown in Figs. 4͑a͒-4͑c͒ . The reconstructed volumes in these images have dimensions 2.5 by 2 mm, and appear similar in shape to those observed in Fig. 3 . As depicted in the bar graph in Fig. 4͑d͒ , the average reconstructed FMT fluorochrome concentrations are approximately equal for the tubes containing 25 and 50 ppm ink, while the average fluorochrome concentration for the tube containing 100-ppm ink was approximately 20% larger. This difference is on the order of the measurement variability, as given by the error bars in Fig.  4͑d͒ . In contrast, a 40% decrease in photon counts was measured between FRI images collected from the fluorescent tubes containing 25 and 100 ppm ink.
Discussion
The quantitative accuracy of fluorescence tomography has been investigated previously. 32, 34 However, these studies involved titrations of known amounts of fluorescent dye into a translucent tube immersed in a turbid solution of intralipid and ink. This idealized experiment utilizing a homogeneous medium may not reflect the performance of FMT in vivo, where biological optical heterogeneity and background fluorescence may complicate the measurement of fluorochrome concentrations. In the present study, we sought to generate a model system in which we could probe the quantitative performance of FMT in living subjects. By creating small clear plastic vessels that were filled with known concentrations of fluorescent dye, we were able to produce a controlled phantom that could be inserted subcutaneously to mimic a subcutaneous tumor model containing a known amount of fluorochrome. Furthermore, by adding intralipid and ink to the fluorochrome solution in the tube, we simulated the biological situation of fluorochromes embedded in a turbid, absorbing tissue. This experimental system allowed the evaluation of the response of FMT to biological heterogeneity, background fluorescence, and local tissue absorption.
FMT reconstructions of measurements taken of the same fluorescent tube both before and after implantation in a nude mouse demonstrate a linear relationship between measured and actual fluorochrome concentration. FMT reconstructions of fluorescent tubes imaged while in a mouse were observed to give larger fluorochrome concentration measurements than when the tubes are imaged in a homogeneous intralipid-ink medium, as seen in Fig. 2 . The slope of the regression between measured and actual fluorochrome concentrations in the in vivo case was 24.7% greater than that in the ex vivo case. This effect can be attributed to the optical heterogeneity of the animal that typically yields a higher net absorption coefficient for photon paths passing through the middle of the torso, because of the heat and other highly absorbing structures, relative to photon paths through boundaries that generally contain low-absorbing adipose tissue. This quantification bias in the presence of increased absorption was also observed in the results of Fig. 4 , and is discussed further below. This discrepancy could be addressed by incorporating independent reconstructions of background absorption, yielding more accurate forward models for fluorescence tomography. An alternative approach is to employ an experiment-based calibration factor derived from animal measurements to improve in vivo quantification. It is important to note that, similar to observations obtained in simpler phantoms, normalized Born methods yield robust reconstruction of subcutaneous fluorescent foci even in the presence of biological heterogeneity.
One of the most exciting possibilities for fluorescence tomography is its application in the detection of molecularspecific fluorescent probes in vivo, permitting noninvasive visualization of a range of biochemical and physiologic activity. In these applications, the sensitivity of FMT to background fluorescence due to nonspecific probe accumulation in tissues within the field of view becomes critical. In this study, we have addressed this issue by injecting mice with implanted subcutaneous fluorescent tubes with a standard dose of a representative fluorescent molecular probe, Cy 5.5 Annexin V. As the animal model does not contain a focus of apoptotic activity in which accumulation of this probe might be expected, the agent follows its normal biodistribution, resulting in distributed, diffuse fluorescent signals throughout the subject. As observed in Figs. 3͑a͒ and 3͑b͒ , FMT measurements of this model to identify the presence of the subcutaneous fluorescent tube. However, there are also low levels of fluorochrome reconstructed in the background, which are not observed in reconstructions of measurements in which the mouse was not injected with a probe. Background fluorescence clearly affects measurement of focal fluorochrome concentrations in a structure of interest, as evidenced by Fig. 3͑b͒ , where a 500 nM target was measured to have a fluorochrome concentration of 600 nM. With increased target fluorochrome concentration, the effect of background fluorescence becomes less noticeable, as observed in Fig. 3͑d͒ .
To advance FMT as an imaging modality capable of quantitatively measuring flurochrome concentrations in heterogeneous, in vivo settings, the influence of background fluorescence on imaging results must be addressed. As a preliminary approach, we applied a correction in which a dc value of 20 counts/ s was subtracted from all fluorescence field measurements prior to image reconstruction. This procedure makes the approximation that the contribution of the background fluorochrome distribution adds 20 counts/ s for each source-detector pair. While this correction proved to be quite effective in this study for generating measurements that are unaffected by background fluorescence, as seen in Fig. 3͑d͒ , it is not a robust means of dealing with background signals. Further work is being conducted to develop adaptive techniques for measuring background fluorescence and subtracting its contribution to the measured fluorescence photon field. Effort is also being directed to develop more sophisticated treatments of photon propagation from small concentrations of distributed fluorochromes, and to develop to more accurately correct for the effects of a background of low intensity fluorescence in in vivo FMT datasets.
As discussed before, tomographic measurements of fluorescence can be greatly influenced by the optical properties of the surrounding medium. However, for measurements of tumors and tumor models targeted by fluorescent contrast agents, the local optical properties of the fluorescent object itself can also be of significance. Different tumor types can exhibit a wide variety of vascular profiles and therefore blood contents. As hemoglobin is a strong photon absorber in the near-infrared band, this can result in different tumors possessing distinct photon absorption properties. We simulated this phenomenon by constructing fluorescent tubes with varying concentrations of black india ink mixed with the intralipid and Cy 5.5 solution. Spectrophotometer measurements verified that the corresponding absorption coefficients of the resulting solutions ranged from 0.15 cm −1 ͑25 ppm ink͒ to 0.6 cm −1 ͑100 ppm ink͒. As seen in Fig. 4͑d͒ , our data suggest that the effect of varying local absorption on fluorochrome concentrations measured by FMT is limited. Tubes with ink concentrations of 25 and 50 ppm ͑ a = 0.15 and 0.3 cm −1 ͒ reconstructed to average fluorochrome concentrations of 489 and 492 nM, respectively, while a tube with 100-ppm ink ͑ a = 0.6 cm −1 ͒ reconstructed to an average fluorochrome concentration of 582 nM. It is encouraging that given a four-fold change in the absorption coefficient of the fluorescent tube, the fluorochrome concentration measured by FMT changed only by approximately 20%. Corrections involving measured or a priori information on absorption heterogeneities in the subject may further reduce this variation and maximize the accuracy of quantitation for FMT. FRI, however, is unable to distinguish changes in absorption from changes in fluorochrome concentrations in the target, as evident by the 40% decrease in photon counts measured from the phantoms with absorption coefficients of 0.15 and 0.6 cm −1 . This benefit of FMT relative to FRI has recently been demonstrated by Ntziachristos et al. by imaging tumors with different degrees of vascularity. 21 The results shown herein were obtained with a secondgeneration FMT prototype employing 31 light sources and an array of 19ϫ 13 detectors sampled from the CCD images acquired. These data were reconstructed using a homogeneous slab solution to the diffusion equation after the normalized Born formulation. This approach demonstrated reduced sensitivity on varying medium optical properties and is experimentally simple to implement, as it is independent of the source and detector gain and several coupling issues between tissue and the optical apparatus. Current research in acquisition hardware and reconstruction techniques for FMT can be expected to further refine the quantitative accuracy of fluorescence tomography in vivo. In particular, optimization studies are shedding light on the source and detector arrays that most effectively balance dataset size and information content for small animal imaging. 41, 42 Also, progress has been made toward more accurately modeling the photon propagation boundaries encountered in FMT, 36, 43 permitting fluorescence tomography without the assumption of a slab geometry, and therefore without bathing the subject in an optical matching fluid. Other groups have also had success in combining high resolution anatomic imaging techniques such as magnetic resonance imaging ͑MRI͒ with diffuse optical tomography, permitting consideration of tissue optical heterogeneity in the tomographic reconstruction process. 44 Finally, in contrast to the diffusion equation-based solutions used herein, the use of forward models based on the transport equation may be used to improve the fluorescence imaging problem, 45 especially in systems with small source-detector separations ͑less than 5 to 10 photon mean-free paths͒ and when imaging through void regions. More advanced theoretical approaches to the problem of photon propagation in tissue can improve the imaging accuracy, especially when imaging absolute quantities. These developments can further improve FMT robustness and image fidelity, and can be used to specifically detect and measure fluorescence in live tissues.
Conclusion
We demonstrate the ability of a fluorescent molecular tomography system to measure fluorochrome concentrations in vivo. Furthermore, we show that the quantitative accuracy of FMT is robust in the presence of varying local photon absorption coefficients. The presence of background fluorescence, modeled here by a previous intravenous injection of a fluorescentlabeled molecular probe in a mouse bearing a fluorescent tube, is seen to offset fluorochrome concentrations measured by FMT for tubes with Cy 5.5 concentrations from 0 to 500 nM Cy 5.5. This effect is reduced by applying a simple correction for background fluorescence to the measured fluorescent field. Advances in FMT hardware and software will further reduce the sensitivity of the technique to background fluorescence and to local absorption. These findings encourage the use of fluorescence tomography as a quantitative technique for measuring molecular-specific fluorescent probes in vivo, supporting the development of this emerging branch of molecular imaging.
